• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Connective tissue disease: Reflections on the EULAR recommendations for the treatment of systemic sclerosis.

作者信息

Pope Janet E

机构信息

St. Joseph's Health Care, 268 Grosvenor St, London, Ontario N6A 4V2, Canada; and at University of Western Ontario, Schulich School of Medicine &Dentistry, 1151 Richmond St, London, Ontario, N6A 5C1, Canada.

出版信息

Nat Rev Rheumatol. 2017 Mar;13(3):134-136. doi: 10.1038/nrrheum.2016.212. Epub 2017 Jan 5.

DOI:10.1038/nrrheum.2016.212
PMID:28053333
Abstract
摘要

相似文献

1
Connective tissue disease: Reflections on the EULAR recommendations for the treatment of systemic sclerosis.结缔组织病：关于欧洲抗风湿病联盟系统性硬化症治疗建议的思考
Nat Rev Rheumatol. 2017 Mar;13(3):134-136. doi: 10.1038/nrrheum.2016.212. Epub 2017 Jan 5.
2
[Iloprost therapy in systemic sclerosis].[伊洛前列素治疗系统性硬化症]
Hautarzt. 2003 Sep;54(9):845-51. doi: 10.1007/s00105-003-0578-2.
3
Raynaud's of the gut? Systemic sclerosis-associated microvascular ischaemic colitis responsive to intravenous iloprost.
Rheumatology (Oxford). 2024 Aug 1;63(8):e219-e221. doi: 10.1093/rheumatology/keae052.
4
Diffuse cutaneous systemic sclerosis treated with intravenous iloprost.静脉注射伊洛前列素治疗弥漫性皮肤型系统性硬化症。
Clin Exp Dermatol. 2004 May;29(3):321-3. doi: 10.1111/j.1365-2230.2004.01529.x.
5
[Iloprost for the treatment of systemic sclerosis].伊洛前列素治疗系统性硬化症
Presse Med. 2008 May;37(5 Pt 2):831-9. doi: 10.1016/j.lpm.2007.06.016. Epub 2007 Nov 26.
6
Possible role of iloprost (stable analog of PG12) in promoting neoangiogenesis in systemic sclerosis.
Clin Exp Rheumatol. 2006 Mar-Apr;24(2):220-1.
7
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.静脉输注伊洛前列素治疗系统性硬化症继发雷诺现象。一项多中心、安慰剂对照、双盲研究。
Ann Intern Med. 1994 Feb 1;120(3):199-206. doi: 10.7326/0003-4819-120-3-199402010-00004.
8
Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels.系统性硬化症相关雷诺现象：伊洛前列素输注疗法对血清细胞因子、生长因子及可溶性黏附分子水平的影响
Acta Derm Venereol. 2001 Aug-Sep;81(4):294-7. doi: 10.1080/00015550152572976.
9
Is iloprost effective in secondary Raynaud's phenomenon?伊洛前列素对继发性雷诺现象有效吗？
Medwave. 2015 Mar 9;15(2):e6082. doi: 10.5867/medwave.2015.02.6082.
10
[Effects of long-term iloprost therapy on Raynaud's phenomenon in progressive systemic sclerosis].[长期伊洛前列素治疗对进行性系统性硬化症雷诺现象的影响]
Minerva Med. 1992 Nov;83(11):739-44.

引用本文的文献

1
The frequency of Raynaud's phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database.在一个大型退伍军人健康管理局数据库中雷诺现象的发生率、系统性硬化症的极早期诊断及系统性硬化症
BMC Rheumatol. 2021 Oct 15;5(1):42. doi: 10.1186/s41927-021-00209-z.

本文引用的文献

1
Update of EULAR recommendations for the treatment of systemic sclerosis.EULAR 系统性硬皮病治疗推荐更新。
Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.
2
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.霉酚酸酯与口服环磷酰胺治疗硬皮病相关间质性肺病（SLS II）：一项随机对照、双盲、平行组试验。
Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.
3
BSR and BHPR guideline for the treatment of systemic sclerosis.
英国风湿病学会和英国卫生与保健改善署系统性硬化症治疗指南
Rheumatology (Oxford). 2016 Oct;55(10):1906-10. doi: 10.1093/rheumatology/kew224. Epub 2016 Jun 9.
4
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.马昔腾坦治疗系统性硬化症患者新发缺血性指端溃疡的效果：DUAL-1 和 DUAL-2 随机临床试验。
JAMA. 2016 May 10;315(18):1975-88. doi: 10.1001/jama.2016.5258.
5
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.托西珠单抗皮下注射治疗系统性硬化症成人患者的安全性和有效性（faSScinate）：一项 2 期、随机、对照试验。
Lancet. 2016 Jun 25;387(10038):2630-2640. doi: 10.1016/S0140-6736(16)00232-4. Epub 2016 May 5.
6
The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review.硬皮病中的 15%规则：系统性硬化症中严重器官并发症的频率。一项系统评价。
J Rheumatol. 2013 Sep;40(9):1545-56. doi: 10.3899/jrheum.121380. Epub 2013 Jul 15.
7
Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.他汀类药物：可能对系统性硬化症相关的雷诺现象和指端溃疡的治疗有用。
J Rheumatol. 2008 Sep;35(9):1801-8. Epub 2008 Aug 15.
8
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases.波生坦对结缔组织病相关肺动脉高压患者生活质量、生存率、安全性及耐受性的长期影响
Ann Rheum Dis. 2008 Sep;67(9):1222-8. doi: 10.1136/ard.2007.079921. Epub 2007 Nov 30.
9
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.一项多中心、前瞻性、随机、双盲、安慰剂对照试验，研究皮质类固醇和静脉注射环磷酰胺随后口服硫唑嘌呤治疗硬皮病相关性肺纤维化的疗效。
Arthritis Rheum. 2006 Dec;54(12):3962-70. doi: 10.1002/art.22204.
10
Scleroderma treatment differs between experts and general rheumatologists.硬皮病的治疗方法在专家和普通风湿病学家之间存在差异。
Arthritis Rheum. 2006 Feb 15;55(1):138-45. doi: 10.1002/art.21714.